What is Johnson & Johnson's consumer health — D&A?

Johnson & Johnson (JNJ) reported consumer health — D&A of $0 in Q4 2025.

What is the long-term trend for Johnson & Johnson's consumer health — D&A?

Over 4 years (2021 to 2025), Johnson & Johnson's consumer health — D&A has grown at a -100.0% compound annual growth rate (CAGR), from $739M to $0.

What does consumer health — D&A mean?

The non-cash expense allocated to the Consumer Health segment to account for the gradual wear and tear of physical assets and the expiration of intangible assets over time. It provides insight into the asset intensity and the age of the capital base supporting this business unit.

Johnson & Johnson JNJ Consumer Health — D&A

Other segment segments

Innovative Medicine

$1.04B+17.2%

MEDTECH

$903M+8.0%

General Corporate

$65M+25.0%

Similar metrics at other companies

ELAConsumer — D&A

$215.1K+19.1%

MMMConsumer — D&A

$40M+2.6%

TWIConsumer — D&A

$4.84M+3.7%

ULSConsumer — D&A

$21M+10.5%

LSAKConsumer — D&A

$774K+204%

EXPOEnvironmental And Health — D&A

$45K-4.3%

Other financials

Income statement

See full

Revenue$24.1B+9.9%

Gross profit$16.0B+9.8%

Operating income$6.3B+2.3%

Net income$5.2B-52.4%

EPS (diluted)$2.14-52.9%

Balance sheet

See full

Cash & equivalents$21.7B-43.6%

Total debt$55.0B+5.2%

Total equity$81.2B+3.9%

Total assets$200.89B+3.7%

Cash flow

See full

Operating cash flow$2.5B-39.8%

CapEx$1.0B+31.9%

Free cash flow$1.5B-56.6%

Valuation

See full

Market cap$623.71B+66.9%

Enterprise value$657.01B+61.9%

P/E29.6×+13.2×

P/S6.5×+2.3×

Profitability

See full

Gross margin67.8%-0.5pp

Operating margin26.4%+2.8pp

Net margin21.8%-2.6pp

FCF margin18.5%-4.3pp

Returns & leverage

See full

Return on equity26.4%-3.0pp

Debt / equity0.7×0.0×

Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Johnson & Johnson’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's consumer health — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's consumer health — D&A?: Johnson & Johnson (JNJ) reported consumer health — D&A of $0 in Q4 2025.
What is the long-term trend for Johnson & Johnson's consumer health — D&A?: Over 4 years (2021 to 2025), Johnson & Johnson's consumer health — D&A has grown at a -100.0% compound annual growth rate (CAGR), from $739M to $0.
What does consumer health — D&A mean?: The non-cash expense allocated to the Consumer Health segment to account for the gradual wear and tear of physical assets and the expiration of intangible assets over time. It provides insight into the asset intensity and the age of the capital base supporting this business unit.